Evidence map›Paper›PMID 42494997›Full record

ArticleNeuro-oncology advances

Population-based validation of the RANO categories for extent of resection in glioblastoma.

Claes Johnstad, Ingerid Reinertsen, David Bouget, Okizeva Rapi, Asgeir S Jakola, Ole Solheim

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Claes JohnstadDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.ORCID https://orcid.org/0009-0005-3928-5706
Ingerid ReinertsenDepartment of Health Research, SINTEF Digital, Trondheim, Norway.ORCID https://orcid.org/0000-0003-0999-3849
David BougetDepartment of Health Research, SINTEF Digital, Trondheim, Norway.ORCID https://orcid.org/0000-0002-5669-9514
Okizeva RapiSection of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Asgeir S JakolaSection of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-2860-9331
Ole SolheimDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.ORCID https://orcid.org/0000-0002-5954-4817

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The RANO Resect group published the updated Methods: This population based retrospective cohort study included 470 consecutive patients treated at two centers in Norway and Sweden. None of the hospitals had a strategy to aim for supramarginal resections. Postoperative contrast-enhanced T1 and FLAIR volumes were used to group the patients according to the RANO categories. Cox models and Kaplan-Meier plots were used for survival analyses. We performed subgroup analyses of patients where the Stupp protocol was initiated, MGMT methylated tumors, and elderly patients (≥70 years). Results: Median overall survival was 16, 15, 11, and 6 months for the respective categories of supramaximal (Class 1), maximal (Class 2), submaximal resection (Class 3), and biopsy only (Class 4). Thirty-five patients (7.5%) were classified as Class 1, despite not aiming for resection beyond the contrast-enhancing tumor. This class had a median tumor volume of only 6 mL, smaller preoperative FLAIR volumes and was associated with improved survival compared to Class 2 (HR = 0.6, Discussion and Conclusion: The RANO categories were associated with survival, but survival was shorter and differences across categories were less than in the original study. Maximal and supramaximal resections were associated with longer survival. One fourth of complete resections were incidentally classified as supramaximal resections, and these patients had a favorable prognosis.

Indexed as

extent of resectionglioblastomaoverall survivalRANO resect

Identifiers

PMID42494997
PMCPMC13395087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.